Announcement of the Center for Drug Evaluation of the State Food and Drug Administration on the issuance of the "Technical Guidelines for Clinical Changes of Listed Chemical Drugs and Biological

        According to the "Announcement of the State Drug Administration on Issues Concerning the Implementation of the Measures for the Administration of Drug Registration" (No. 46, 2020), in order to promote the supporting work of related documents, under the deployment of the State Drug Administration, the Center for Drug Evaluation has organized and formulated The "Technical Guidelines for Clinical Changes of Listed Chemical Drugs and Biological Products" (see appendix). In accordance with the requirements of the "Notice of the General Department of the State Drug Administration on Printing and Distributing the Procedures for the Publication of Drug Technical Guidelines" (Yao Jian Zong Yao Guan [2020] No. 9), it is hereby issued with the approval of the State Drug Administration, as of the date of issuance From implementation.

        announce.
                                                                                                                  






Attachment 1: "Technical Guidelines for Clinical Changes of Listed Chemical Drugs and Biological Products".pdf